Radnet Inc
General ticker "RDNT" information:
- Sector: Health Care
- Industry: Health Care Providers & Services
- Capitalization: $5.8B
Radnet Inc follows the US Stock Market performance with the rate: 68.8%.
Estimated limits based on current volatility of 2.0%: low 71.07$, high 74.01$
Factors to consider:
- Current price 57.7% above estimated high
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [27.69$, 46.06$]
- 2024-12-30 to 2025-12-30 estimated range: [32.06$, 52.13$]
Financial Metrics affecting the RDNT estimates:
- Positive: 0.10 < Non-GAAP EPS, $ of 0.50
- Positive: 1.03 < Operating profit margin, % of 6.07
- Negative: Industry operating profit margin (median), % of 0.95 <= 2.14
- Positive: Industry inventory ratio change (median), % of 0 <= 0
Short-term RDNT quotes
Long-term RDNT plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $1,303.27MM | $1,427.53MM | $1,626.11MM |
| Operating Expenses | $1,220.71MM | $1,381.17MM | $1,527.41MM |
| Operating Income | $82.55MM | $46.36MM | $98.70MM |
| Non-Operating Income | $-23.68MM | $-3.39MM | $-59.89MM |
| Interest Expense | $48.83MM | $50.84MM | $64.48MM |
| Income(Loss) | $58.88MM | $42.97MM | $38.81MM |
| Taxes | $14.56MM | $9.36MM | $8.47MM |
| Profit(Loss) | $44.32MM | $33.61MM | $30.34MM |
| Stockholders Equity | $228.90MM | $333.00MM | $630.70MM |
| Assets | $2,058.47MM | $2,433.91MM | $2,690.47MM |
| Operating Cash Flow | $149.49MM | $146.42MM | $220.86MM |
| Capital expenditure | $220.69MM | $249.41MM | $176.60MM |
| Investing Cash Flow | $-221.51MM | $-246.95MM | $-201.47MM |
| Financing Cash Flow | $104.67MM | $93.65MM | $195.63MM |
| Earnings Per Share* | $0.84 | $0.60 | $0.05 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.